Lorcaserin Extended-Release Tablets and Omalizumab Subcutaneous
Determining the interaction of Lorcaserin Extended-Release Tablets and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, and Ritonavir
- Lorcaserin Extended-Release Tablets-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Lorcaserin Extended-Release Tablets-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Lorcaserin Extended-Release Tablets-Omeclamox-Pak
- Lorcaserin Extended-Release Tablets-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Lorcaserin Hydrochloride
- Omalizumab Subcutaneous-Lorcaserin Tablets
- Omalizumab Subcutaneous-Lorcet
- Omalizumab Subcutaneous-Lorcet Plus
- Omalizumab Subcutaneous-Lorcet Tablets
- Omalizumab Subcutaneous-Lorlatinib